Abstract
Azadirachta indica (neem) is a tropical and semi-tropical tree native to the whole Indian subcontinent. Neem leaves are rich in flavonoids, which exhibit important pharmacological activities targeting almost all human organs. In order to produce a purified extract of neem leaves enriched of antioxidant and antidiabetic flavonoids, the ethanolic extract of neem leaves has been further undergone to liquid-liquid extractions by using three different organic solvents, i.e. dichloromethane, n-butanol and ethyl acetate. Qualitative and quantitative analyses were performed on the extracts obtained by thin layer chromatography (TLC) and high performance liquid chromatography (HPLC). Astragalin, quercitrin, isoquercitrin, nicotiflorin and rutin were the only flavonoids found among those screened. By comparing all HPLC chromatograms of purified extracts as obtained with different solvents, it was found that the qualitative-quantitative composition of flavonoids depends upon the extraction solvent used; in particular, dichloromethane allows extraction of 89.5 % quercitrin, 5.3 % isoquercitrin, 5.2 % rutin; n-butanol allows extraction of 6.0 % isoquercitrin, 6.2 % nicotiflorin, 87.8 % rutin; ethyl acetate allows extraction of 4.2 % astragalin, 12.0 % quercitrin, 50.3 % isoquercitrin, 6.7 % nicotiflorin, 26.9 % rutin. Thus, depending on the specific purposes and needs, each of these three extraction solvents has the potential to prepare formulations enriched with the most suitable flavonoids composition.
Introduction
Neem is an evergreen, temperature tolerant, flowering plant, native to the whole Indian subcontinent, which can be found growing in a lot of tropical and semi-tropical countries located in the equatorial belt. Botanically it is classified as a member of the family Meliaceae, under the latinised name Azadirachta indica A. Juss (A. indica). This name derives from the Persian words “azad” (free), “darakht” (tree) and “i-hind” (of Indian origin), which literally mean “the free tree of India” [1]. All part of the neem tree (root, bark, leaves, flowers, seeds and fruits) are used to treat or prevent a wide range of diseases [2]. Neem leaves are considered the most versatile part of the plant and contain several natural compounds, showing many biological activities, exploited to treat various diseases and disorders, by including sexually transmitted disease pathogens, HIV/AIDS and cancer [2], [3].
Flavonoids have existed for over one billion years in vegetables and possess wide spectrum of biological activities [4]. These polyphenolic compounds are present both in the aqueous and ethanolic leaf extract of neem [5]. In particular, the content of total flavonoids in different crude extracts prepared from neem leaves is in the range of 61.5–529.5 mg/100 g powder sample [6]. Some studies show that the ingestion of flavonoids reduces the risk of cardiovascular diseases, metabolic disorders, and certain types of cancer. These effects are due to the physiological activity of flavonoids in the reduction of oxidative stress, inhibiting low-density lipoproteins oxidation as well as platelet aggregation, and acting as vasodilators in blood vessels [4]. Dini et al. found that the hydro-alcoholic extract of A. indica leaves prevents streptozotocin-induced intestinal ileal and pancreatic islet lesions, ameliorating the hepatic glycogenosis, pancreatic and liver oxidative status of diabetic rats [7], [8], [9]. These in vivo-observed biological activities could be due to the presence of flavonoid compounds in the extract, especially those exhibiting antioxidant and antidiabetic properties. Therefore, with the prospect to produce drugs, food supplements, cosmetics and other products based on the purified neem leaves extract enriched with a specific composition of these flavonoids, the ethanolic leaf extract of A. indica underwent further liquid-liquid extractions by using three different organic solvents with an increasing Rohrschneider and Snyder solvent polarity parameter, i.e. dichloromethane<n-butanol<ethyl acetate [10], chosen among those exhibiting no safety concerns when used as a flavouring agents in food and beverage industries [database of FAO/WHO Expert Committee on Food Additives (JECFA); PubChem database of National Institutes of Health (NIH)]. Qualitative and quantitative analyses were carried out on each extract by using thin layer chromatography (TLC) and high performance liquid chromatography (HPLC). The chemical characteristics and main biological activities of the investigated flavonoids are summarized in Table 1.
Chemical characteristics and main biological activities of antioxidant and antidiabetic flavonoids investigated.
| Name | Formula | Mol. weight (g/mol) | Main biological activities | ||
|---|---|---|---|---|---|
| IUPAC | Trivial | Chemical | Structural | ||
| 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one | Quercetin | C15H10O7 | ![]() | 302.238 | Protective abilities against several degenerative diseases by preventing lipid peroxidation and against tissue injury induced by various drug toxicities [4] |
| 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one | Myricetin | C15H10O8 | ![]() | 318.237 | Carbohydrate metabolic enzymes and insulin signalling molecules enhancing in streptozotocin-cadmium induced diabetic nephrotoxic rats [11] |
| 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one | Astragalin | C21H20O11 | ![]() | 448.380 | Anti-inflammatory, antioxidant, neuroprotective, cardioprotective, antiobesity, antiosteoporotic, anticancer, antiulcer and antidiabetic properties [12] |
| 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxychromen-4-one | Quercitrin | C21H20O11 | ![]() | 448.380 | Plasma glucose decrement, insulin levels increment, and antioxidant status improving in streptozotocin-induced diabetic rats by decreasing lipid peroxidative products and increasing enzymic and nonenzymic antioxidants [13] |
| 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one | Isoquercitrin | C21H20O12 | ![]() | 464.379 | Chemoprotective effects both in vitro and in vivo, against oxidative stress, cancer, cardiovascular disorders, diabetes and allergic reactions [14] |
| 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S, 3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R, 4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one | Nicotiflorin | C27H30O15 | ![]() | 594.522 | Antioxidant and immunoregulation properties protecting the liver against acute immunological and chemical injury [15] |
| 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one | Rutin | C27H30O16 | ![]() | 610.521 | Decrement in plasma glucose, augmentation in insulin levels, and restitution of glycogen content and glycolytic enzymes in streptozotocin-induced diabetic rats [16] |
Materials and methods
Collection and extracts of A. indica leaves
Mature fresh leaves of A. indica (A. Juss) were collected in the premises of the University of Ilorin, Mini Campus, Nigeria, between June and August 2007 (a sample of the collection was identified and compared with the voucher specimen at the herbarium of the Botany Department of the same University, Voucher No. 542). These leaves were air-dried at room temperature (RT) and extracted by percolation as described in 1999 by Chattopadhyay [17]. Briefly, a total of 2 kg of the dry leaf powder was extracted at RT by using 70% ethanol (v/v in bi-distilled water); the alcoholic solution was filtered with Whatman No. 1 paper and concentrated under vacuum by using a Buchi Rotavapor R-114 (Buchi, Switzerland) at 50°C (bath temperature); the concentrated solution was dissolved in bi-distilled water and filtered with Whatman No. 1 paper; the filtrate was concentrated by using a rotavapor set at 50°C (bath temperature). The final yield (about 120 g) was a dark-brown sticky mass, which was stored at 4°C.
About 3 g of A. indica leaf extract were solubilized in 50 ml of bi-distilled water and placed into a 200 ml separating funnel to undergo multiple liquid-liquid extractions by using three organic solvents with an increasing Rohrschneider and Snyder solvent polarity parameter (P′), i.e. dichloromethane (P′=3.1, according to Menet and Thiebaut [10]; CAS number: 75-09-2), n-butanol (P′=3.9, according to Menet and Thiebaut [10]; CAS number: 76-36-3) and ethyl acetate (P′=4.4, according to Menet and Thiebaut [10]; CAS number: 141-78-6), chosen among those exhibiting no safety concerns (degree of safety: n-butanol>ethyl acetate>dichloromethane) when used as a flavouring agents in food and beverage industries (database of JECFA available at URL: http://apps.who.int/food-additives-contaminants-jecfa-database/search.aspx; PubChem database of NIH available at URL: https://pubchem.ncbi.nlm.nih.gov/). Three consecutive extractions were carried out for each solvent used, by adding 50 ml of solvent every time.
To identify the flavonoid compounds, the hydro-alcoholic A. indica leaf extract was solubilized in bi-distilled water and analysed by thin-layer chromatography (TLC). Whereas, to quantify the flavonoid compounds, the initial hydro-alcoholic extract, the three organic phases obtained as a result of the various differentiated extractions and the remaining aqueous phase were analysed by high-performance liquid chromatography (HPLC).
Thin-layer chromatography (TLC)
Using two different glass capillaries, a spot (about 10 μl) of the aqueous solutions (60 mg/ml in bi-distilled water) containing the A. indica hydro-alcoholic leaf extract or the standard flavonoid reference mixture (2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one (quercetin), 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one (myricetin), 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6- (hydroxymethyl)oxan-2-yl]oxychromen-4-one (astragalin), 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R, 4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxychromen-4-one (quercitrin), 2-(3,4-dihydroxyphenyl)-5,7- dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one (isoquercitrin), 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one (nicotiflorin) and 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one (rutin) – LabService Analytica srl, Italy) were applied on a TLC silica gel 60 G sized 10×10×0.02 cm and coated with the fluorescent indicator F254 (EMD Millipore, Merck KGaA, Darmstadt, Germany), about 1.5 cm from the bottom edge. The solvent (bi-distilled water) was allowed to completely evaporate off under a vacuum chamber. The plate was immersed into a glass separation chamber containing an eluent composed of 72.5% ethylacetate, 7.5% acetic acid, 7.5% formic acid and 12.5% bi-distilled water (Sigma-Aldrich, MO, USA).
To detect the flavonoid compounds present in the mixture of standards and in the hydro-alcoholic A. indica leaf extract, a UV lamp set at 254 and 366 nm (UV Lamp 4 with Two UV tubes for illumination (1×UV 254 nm and 1×UV 366 nm, each 8 W) – CAMAG Chemie-Erzeugnisse and Adsorptionstechnik AG, Switzerland), iodine vapours and phosphomolybdic acid as chemical agents (Sigma-Aldrich, USA), were used. The identification of flavonoids has been made by comparing the retardation factor (migration distance of sample/migration distance of solvent front) of the bands of the sample vs. the reference standards.
High-performance liquid chromatography (HPLC)
HPLC chromatographic analysis was carried out at RT by using a Hewlett-Packard 1100 Series HPLC System (Hewlett-Packard, CA, USA), consisting of a binary pump based on the high-pressure mixing principle and a detector consisting of a UV-visible spectrophotometer with a variable wavelength. The injections were made by using a Rheodyne HP 7725 manual injector with a 20 μl sample loop (Rheodyne, CA, USA). The type of HPLC column used was the Lichrospher RP-18 (Supelco/Sigma-Aldrich, PA, USA) 250 mm×4.6 mm (i.d.=5 mm), with a stationary phase C18. Data provided by this system was collected and processed by using HP ChemStation software for LC systems (Agilent Technologies, CA, USA). A flow of 1 ml/min was used and the UV detector was set to a wavelength of 366 nm. Five HPLC injections were performed (30 min in total for each run) by using acetonitrile with 0.1% formic acid and water for HPLC (bi-distilled with Millipore Milli-Q Plus ZD5211584) with 0.1% of formic acid (JT Baker, Avantor Performance Materials LLC, PA, USA) as organic (A) and aqueous (B) solvents of mobile phase, respectively. Changes made in the mobile phase composition during the HPLC run are summarized in Table 2.
HPLC gradient elution program.
| Time (min) | Percentages (v/v) | |
|---|---|---|
| Solvent A | Solvent B | |
| 0th | 20 | 80 |
| 9.5th | 28 | 72 |
| 20th | 100 | 0 |
| 25th | 100 | 0 |
| 30th | 20 | 80 |
A, Acetonitrile with 0.1% formic acid; B, Water for HPLC with 0.1% of formic acid.
Six solutions of standard flavonoids (1000, 500, 250, 100, 50, 25, 0.1 μg/ml of methanol) were prepared and subjected to HPLC analysis. The calibration curves were constructed by plotting the average peak areas vs. the concentrations of standard flavonoid. The chromatogram for the blank solvent was subtracted from sample chromatogram to correct the background error. Finally, the quantity of each detected flavonoid was determined using the regression equation (y=ax±b), where x is the concentration (expressed in μg/ml or ppm) and y is the peak area of each flavonoid derived from the calibration curve of each respective standard. The linearity was established by the coefficient of determination (R2).
Statistical analysis
Data were analysed by performing one-way analysis of variance (ANOVA) at the 95% confidence level. P-values less than 0.05 were considered significant. Data are reported as mean±standard error (SE) of five independent experiments each one done in duplicate.
Results and discussion
The TLC running with the hydro-alcoholic A. indica extract and pure standard flavonoids in co-chromatography indicated that astragalin, quercitrin, isoquercitrin, nicotiflorin and rutin were the only flavonoids found in the hydro-alcoholic extract among those screened (Table 3; [17]).
Analytes present (+) or absent (−) in the hydro-alcoholic extract of A. indica matching the standard flavonoid reference mixture as identified by TLC.
| Flavonoid compound | Presence (+) or absence (−) |
|---|---|
| Quercetin | − |
| Myricetin | − |
| Astragalin | + |
| Quercitrin | + |
| Isoquercitrin | + |
| Nicotiflorin | + |
| Rutin | + |
Flavonoids were identified by matching both HPLC retention times (tR) and their spectral characteristics against those of standard references. As shown in Table 4, the differences (%) between the tR mean value of standard references vs. the tR mean value of different extracts never exceed 1.15%, therefore fully in accordance with the European Commission Decision 2002/657/EC implementing Council Directive 96/23/EC about the performance of analytical methods and the interpretation of results, which suggests that “The ratio of the chromatographic tR of the analyte to that of the internal standard, i.e. the relative tR of the analyte, shall correspond to that of the calibration solution at a tolerance of ±2.5% for liquid chromatography”.
HPLC retention times (tR) of flavonoids in the reference (standards) and in the different extract solutions (samples).
| Flavonoids | tR (min) | ||
|---|---|---|---|
| Standards (mean, range) | Samples (mean, range) | Difference (%) | |
| Rutin | 7.20 (7.110–7.290) | 7.19a (7.141–7.234) | 0.17 |
| Isoquercitrin | 8.53 (8.423–8.637) | 8.58a (8.522–8.630) | 0.54 |
| Nicotiflorin | 9.01 (8.897–9.123) | 9.10a (9.058–9.135) | 0.95 |
| Astragalin | 10.51 (10.379–10.641) | 10.63a (10.611–10.651) | 1.14 |
| Quercitrin | 10.88 (10.744–11.016) | 10.86a (10.791–10.927) | 0.19 |
| Myricetin | 13.91 (13.736–14.084) | n.d. | – |
| Quercetin | 15.72 (15.524–15.917) | n.d. | – |
tR, Retention time; n.d., not detected; aindicates tR mean sample values significantly different from tR mean standard reference values regarding the same flavonoid (P<0.05).
The content of each flavonoid has been determined by using calibration curves (not shown). By comparing the HPLC chromatograms of purified extracts obtained with the different solvents, it was found that the qualitative-quantitative composition of flavonoids is dependent on extracting solvent (Fig. 1). This outcome is in accord with the finding of Anokwuru et al. [18], who showed as the amount of flavonoids is dependent on the solvent used for extraction. The flavonoid concentrations in ppm for each extracting solvent used are reported in Table 5. The total content of all screened flavonoids, such as found in the ethanolic extract prepared from neem leaves, is 15.9 mg/ml/g powder sample. As expected, this concentration decreased and varied as phytochemicals composition in all different extracts obtained. In particular, dichloromethane allows extraction of 89.5% quercitrin, 5.3% isoquercitrin, 5.2% rutin (total content of all screened flavonoids=0.2 mg/ml/g powder sample); n-butanol allows extraction of 6.0% isoquercitrin, 6.2% nicotiflorin, 87.8% rutin (total content of all screened flavonoids=7.5 mg/ml/g powder sample); ethyl acetate allows extraction of 4.2% astragalin, 12.0% quercitrin, 50.3% isoquercitrin, 6.7% nicotiflorin, 26.9% rutin (total content of all screened flavonoids=4.3 mg/ml/g powder sample). Each of these flavonoids is an antioxidant and/or antidiabetic agent (Table 1). Since for each extract varies both the concentration and the type of flavonoid present, the extent of these biological activities is predicted to vary accordingly.

Representative HPLC chromatograms (at 366 nm) of the initial hydro-alcoholic extract of A. indica (a) and the relative dichloromethane (b), n-butanol (c), ethyl acetate (d) organic, and the remaining aqueous (e) phases obtained from it.
Concentrations of antioxidant and antidiabetic flavonoids as quantified by HPLC.
| Ppm mean ±SD | CV % | Ppm mean±SD | CV % | Ppm mean±SD | CV % | Ppm mean±SD | CV % | Ppm mean±SD | CV % | Ppm mean±SD | CV % | Ppm mean±SD | CV % | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Flavonoid compound | ||||||||||||||
| Quercetin | Myricetin | Astragalin | Quercitrin | Isoquercitrin | Nicotiflorin | Rutin | ||||||||
| Initial hydro-alcoholic extract | ||||||||||||||
| – | – | – | – | 780.2±6.9 | 0.9 | 2170.1±14.7 | 0.7 | 9233.4±47.4 | 0.5 | 2886.5±16.5 | 0.6 | 32705.8±261.6 | 0.8 | |
| Organic phases obtained as a result of the various differentiated extractions | ||||||||||||||
| Dichloromethane | – | – | – | – | – | – | 598.6±2.4 | 0.4 | 35.4±0.1 | 0.3 | – | – | 34.6±0.3 | 0.9 |
| n-Butanol | – | – | – | – | – | – | – | – | 1339.9±7.9 | 0.6 | 1390.6±11.5 | 0.8 | 19715.4±34.7 | 0.2 |
| Ethyl acetate | – | – | – | – | 534.4±1.2 | 0.2 | 1538.1±8.1 | 0.5 | 6463.3±44.6 | 0.7 | 860.0±2.3 | 0.3 | 3459.2±14.8 | 0.4 |
| Remaining aqueous phase | ||||||||||||||
| – | – | – | – | – | – | – | – | - | – | – | – | 383.1±2.2 | 0.6 | |
Mean, Average value of five independent experiments; SD, standard deviation; CV, coefficient of variation.
For the same ethanolic extract of neem leaves herein prepared, both antidiabetic and antioxidant properties have been already demonstrated in mice [7], [8], [9]. In 2011 Bhat et al. [19] found that the chloroform extract of A. indica, when administered for up 21 days to diabetic mice, induces: (i) a gradual decrease in fasting glucose level and a significant weight gain comparable to the control, indicating an increase in muscle mass; (ii) normalizes both the plasma insulin and c-peptide levels; (iii) as also happens with the aqueous extract, inhibits intestinal glucosidases; (iv) an increase in both liver and muscle glycogen content, as well as of the activity of islets producing insulin. In addition, is well tolerated when administered orally, showing an IC50 of 7.5 mg/ml. Flavonoids and other phytochemicals like alkaloids, sesquiterpene and saponins, polysaccharides, dietary fibers, ferulic acid, tannins, limonene, and oleuropeoside have direct or indirect effect in diabetes pathways as enzyme inhibitors. The most involved mechanisms are inhibition of intestinal α-glucosidase and α-amylase, lens aldose reductase, oxidative stress protection, inhibition of formation of advanced glycation end products, inhibition of aldose reductase, lowering plasma glucose levels, altering enzyme activity of hexokinases and glucose-6-phosphate (G6P), synthesizing and releasing of insulin, postprandial hyperglycemia inhibition, stimulation of the glucose transporter type 4 (GLUT-4), decreasing activity of G6P, lowering the level of skeletal hexokinases, etc. [17], [20], [21]. The molecular bases of many diseases, by including diabetes, are known to involve oxidative stress caused by free radicals. Most of the studies reveal the inference of oxidative stress in diabetes pathogenesis by the alteration in enzymatic systems, lipid peroxidation, impaired glutathione metabolism and decreased vitamin C levels [22]. Oxidative stress plays also a role in the development of complications of both types of diabetes mellitus [23]. Sithisarn et al. [24], [25] assessed neem leaves, fruits, flowers and stem bark extracts for their antioxidant activity and inhibition of lipid peroxidation in ChaGo K-1 cancer cells for up 24 h. Leaf aqueous, flower and stem bark ethanol extracts exhibited higher free radical scavenging effect on the 1,1-diphenyl-2-picryl hydrazyl (DPPH) assay with 50% scavenging activity at 26.5, 27.9 and 30.6 μg/ml, respectively; the total antioxidant activity of these extracts was found to be 0.959, 0.988 and 1.064 mM of standard 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (trolox), respectively. At 100 μg/ml, the flower ethanol and leaf aqueous extracts significantly decreased malondialdehyde (MDA) levels (46.0 and 50.6%, respectively), such as detected by the thiobarbituric acid reactive substances (TBARS) method. The same authors speculated that flavonoids might play a role in all these observed antioxidant activities. In 2011, Choudhary and Swarnkar [26], by analysing both leaves and stem bark of A. indica, have provided evidence-based data that the DPPH radical scavenging activity is positively correlated with the total phenolic content and that superoxide radical scavenging activity increases with increasing flavonoids content. The underlying molecular mechanism remains poorly understood, therefore needs further investigation.
Conclusions
Azadirachta indica can be regarded as a valuable plant source in paving a frontier in the field of drug discovery [27]. Even though different parts of this plant have been studied and reported to contain many bioactive compounds that are exploited to treat various diseases and disorders [2], [3], the current research shows that:
in accord to the chemical analysis performed by Chattopadhyay in 1999 [17], astragalin, quercitrin, isoquercitrin, nicotiflorin and rutin contained in the ethanolic extract of A. indica could contribute to its antihyperglycemic/hypoglycemic effect. Thus, these flavonoids, in association with their antioxidant property, could be employed as an alternative source of medicine to mitigate/counteract the pathogenesis of diabetes and its complications;
by depending on specific purposes and needs, the organic solvents dichloromethane, n-butanol and ethyl acetate could be used like extracting solvents to prepare drugs, food supplements, cosmetics and other products that are based on the purified neem leaves extract enriched with the most suitable flavonoids formulation.
In addition, by considering the huge market of the formulations based on the neem leaves in the world, HPLC could be used as elective analytical technique to unmask herbal formulations containing A. indica of poor quality if already on the market, as well as to perform qualitative investigations regarding other products still to be marketed [28].
Article note
A collection of invited papers based on presentations at the 15th Eurasia Conference on Chemical Sciences (EuAsC2S-15), Rome (Italy), 5–8 September 2018.
Acknowledgements
The authors are indebted to Dr. Oluwole B. Akinola from the Department of Anatomy, Faculty of Basic Medical Sciences, University of Ilorin (Ilorin, Nigeria), for the A. indica leaf powder supply.
References
[1] National Research Council (US) Panel on Neem. In: Neem: A Tree for Solving Global Problems, Chapter 3: The Tree, p. 23. National Academies Press, Washington (1992).Search in Google Scholar
[2] M. A. Alzohairy. Evid. Based Complement. Alternat. Med.2016, 7382506 (2016).Search in Google Scholar
[3] N. Bhattacharyya, M. Chutia, S. Sarma. J. Plant Sci.2, 251 (2007).10.3923/jps.2007.251.259Search in Google Scholar
[4] A. V. Anand David, R. Arulmoli, S. Parasuraman. Pharmacogn. Rev.10, 84 (2016).10.4103/0973-7847.194044Search in Google Scholar
[5] G. K. Prashanth, G. M. Krishnaiah. Int. J. Adv. Eng. Technol. Manag. Appl. Sci.1, 21 (2015).Search in Google Scholar
[6] H. S. Khamis Al-Jadidi, M. A. Hossain. Beni-Suef Univ. J. Basic Appl. Sci.4, 93 (2015).10.1016/j.bjbas.2015.05.001Search in Google Scholar
[7] O. B. Akinola, E. A. Caxton-Martins, L. Dini. Int. J. Morphol.28, 291 (2010).10.4067/S0717-95022010000100043Search in Google Scholar
[8] O. B. Akinola, O. O. Dosumu, O. S. Akinola, L. Zatta, L. Dini, E. A. Caxton-Martins. Int. J. Phytomed.2, 320 (2010).Search in Google Scholar
[9] O. B. Akinola, L. Zatta, O. O. Dosumu, O. S. Akinola, A. A. Adelaja, L. Dini, E. A. Caxton-Martins. Pharmacologyonline3, 872 (2009).Search in Google Scholar
[10] J.-M. Menet, D. Thiebaut. In: Countercurrent Chromatography, p. 9. Marcel Dekker Inc., New York (1999).10.1201/9781482273809Search in Google Scholar
[11] N. Kandasamy, N. Ashokkumar. Toxicol. Appl. Pharmacol.279, 173 (2014).10.1016/j.taap.2014.05.014Search in Google Scholar
[12] A. Riaz, A. Rasul, G. Hussain, M. K. Zahoor, F. Jabeen, Z. Subhani, T. Younis, M. Ali, I. Sarfraz, Z. Selamoglu. Adv. Pharmacol. Sci.2018, 9794625 (2018).10.1155/2018/9794625Search in Google Scholar
[13] R. Babujanarthanam, P. Kavitha, U. S. Mahadeva Rao, M. R. Pandian. Mol. Cell. Biochem.358, 121 (2011).10.1007/s11010-011-0927-xSearch in Google Scholar
[14] K. Valentová, J. Vrba, M. Bancířová, J. Ulrichová, Křen V. Food Chem. Toxicol.68, 267 (2014).10.1016/j.fct.2014.03.018Search in Google Scholar
[15] J. Zhao, S. Zhang, S. You, T. Liu, F. Xu, T. Ji, Z. Gu. Int. J. Mol. Sci.18, 587 (2017).10.3390/ijms18030587Search in Google Scholar
[16] A. Ganeshpurkar, A. K. Saluja. Saudi Pharm. J.25, 149 (2017).10.1016/j.jsps.2016.04.025Search in Google Scholar
[17] R. R. Chattopadhyay. J. Ethnopharmacol.67, 373 (1999).10.1016/S0378-8741(99)00094-XSearch in Google Scholar
[18] C. P. Anokwuru, G. N. Anyasor, O. Ajibaye, O. Fakoya, P. Okebugwu. Nat. Sci.9, 53 (2011).Search in Google Scholar
[19] M. Bhat, S. K. Kothiwale, A. R. Tirmale, S. Y. Bhargava, B. N. Joshi. Evid. Based Complement. Alternat. Med.2011, 561625 (2011).10.1093/ecam/nep033Search in Google Scholar
[20] F. Alam, Z. Shafique, S. T. Amjad, M. H. H. Bin Asad. Phytother. Res.33, 41 (2019).10.1002/ptr.6211Search in Google Scholar PubMed
[21] M. I. Kazeem, T. V. Dansu, S. A. Adeola. Pak. J. Biol. Sci.16, 1358 (2013).10.3923/pjbs.2013.1358.1362Search in Google Scholar
[22] U. Asmat, K. Abad, K. Ismail. Saudi Pharm. J.24, 547 (2016).10.1016/j.jsps.2015.03.013Search in Google Scholar
[23] F. A. Matough, S. B. Budin, Z. A. Hamid, N. Alwahaibi, J. Mohamed. Sultan Qaboos Univ. Med. J.12, 5 (2012).10.12816/0003082Search in Google Scholar
[24] P. Sithisarn, R. Supabphol, W. Gritsanapan. Med. Princ. Pract.15, 219 (2006).10.1159/000092185Search in Google Scholar
[25] P. Sithisarn, R. Supabphol, W. Gritsanapan. J. Ethnopharmacol.13, 109 (2005).10.1016/j.jep.2005.02.008Search in Google Scholar
[26] R. K. Choudhary, P. L. Swarnkar. Nat. Prod. Res.25, 1101 (2011).10.1080/14786419.2010.498372Search in Google Scholar
[27] J. M. van der Nat. J. Ethnopharmacol.35, 1 (1991).10.1016/0378-8741(91)90131-VSearch in Google Scholar
[28] S. Desai, P. Tatke, S. Gabhe. J. Chromatogr. Sci.55, 706 (2017).10.1093/chromsci/bmx024Search in Google Scholar PubMed
©2019 IUPAC & De Gruyter. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. For more information, please visit: http://creativecommons.org/licenses/by-nc-nd/4.0/
Articles in the same Issue
- Frontmatter
- In this issue
- Preface
- 15th Eurasia Conference on Chemical Sciences (EuAsC2S-15) – 5th–8th September 2018, Rome, Italy
- Conference papers
- The Jahn-Teller effect in mixed aqueous solution: the solvation of Cu2+ in 18.6% aqueous ammonia obtained from ab initio quantum mechanical charge field molecular dynamics
- Facile synthesis of hydrogel-nickel nanoparticle composites and their applications in adsorption and catalysis
- The effect of pore morphology on the catalytic performance of β-glucosidase immobilized into mesoporous silica
- Competitive pseudo-ELISA based on molecularly imprinted nanoparticles for microcystin-LR detection in water
- Titanium based complexes with melanin precursors as a tool for directing melanogenic pathways
- Stability of PMMA-grafted/Ti hybrid biomaterial interface in corrosive media
- High performance liquid chromatographic profiling of antioxidant and antidiabetic flavonoids purified from Azadirachta indica (neem) leaf ethanolic extract
- Effects mediated by M2 muscarinic orthosteric agonist on cell growth in human neuroblastoma cell lines
- Heterogeneous palladium SALOPHEN onto porous polymeric microspheres as catalysts for heck reaction
- Transfer of chemical elements from milk to dairy products
- Is hydrogen electronegativity higher than Pauling’s value? New clues from the 13C and 29Si NMR chemical shifts of [CHF3] and [SiHF3] molecules
- How alkali-activated Ti surfaces affect the growth of tethered PMMA chains: a close-up study on the PMMA thickness and surface morphology
- Dual inhibitors of urease and carbonic anhydrase-II from Iris species
- Electrochemical synthesis and amidation of benzoin: benzamides from benzaldehydes
Articles in the same Issue
- Frontmatter
- In this issue
- Preface
- 15th Eurasia Conference on Chemical Sciences (EuAsC2S-15) – 5th–8th September 2018, Rome, Italy
- Conference papers
- The Jahn-Teller effect in mixed aqueous solution: the solvation of Cu2+ in 18.6% aqueous ammonia obtained from ab initio quantum mechanical charge field molecular dynamics
- Facile synthesis of hydrogel-nickel nanoparticle composites and their applications in adsorption and catalysis
- The effect of pore morphology on the catalytic performance of β-glucosidase immobilized into mesoporous silica
- Competitive pseudo-ELISA based on molecularly imprinted nanoparticles for microcystin-LR detection in water
- Titanium based complexes with melanin precursors as a tool for directing melanogenic pathways
- Stability of PMMA-grafted/Ti hybrid biomaterial interface in corrosive media
- High performance liquid chromatographic profiling of antioxidant and antidiabetic flavonoids purified from Azadirachta indica (neem) leaf ethanolic extract
- Effects mediated by M2 muscarinic orthosteric agonist on cell growth in human neuroblastoma cell lines
- Heterogeneous palladium SALOPHEN onto porous polymeric microspheres as catalysts for heck reaction
- Transfer of chemical elements from milk to dairy products
- Is hydrogen electronegativity higher than Pauling’s value? New clues from the 13C and 29Si NMR chemical shifts of [CHF3] and [SiHF3] molecules
- How alkali-activated Ti surfaces affect the growth of tethered PMMA chains: a close-up study on the PMMA thickness and surface morphology
- Dual inhibitors of urease and carbonic anhydrase-II from Iris species
- Electrochemical synthesis and amidation of benzoin: benzamides from benzaldehydes






